33429798|t|Intraoperative monitoring parameters and postoperative delirium: Results of a prospective cross-sectional trial.
33429798|a|ABSTRACT: Postoperative delirium (PODE) can be associated with severe clinical complications; therefore, preventive measures are important. The objective of this trial was to elucidate whether haemodynamic or electroencephalographic (EEG) monitoring parameters during general anaesthesia or sevoflurane dosage correlate with the incidence of PODE. In addition, sevoflurane dosages and EEG stages during the steady state of anaesthesia were analyzed in patients of different ages.Eighty adult patients undergoing elective abdominal surgery received anaesthesia with sevoflurane and sufentanil according to the clinical routine. Anaesthesiologists were blinded to the EEG. Haemodynamic parameters, EEG parameters, sevoflurane dosage, and occurrence of PODE were analyzed.Thirteen patients (4 out of 33 women, 9 out of 47 men) developed PODE. Patients with PODE had a greater mean arterial pressure (MAP) variance (267.26 (139.40) vs 192.56 (99.64) mmHg2, P = .04), had a longer duration of EEG burst suppression or suppression (27.09 (45.32) vs 5.23 (10.80) minutes, P = .03), and received higher minimum alveolar sevoflurane concentrations (MAC) (1.22 (0.22) vs 1.09 (0.17), P = .03) than patients without PODE. MAC values were associated with wide ranges of EEG index values representing different levels of hypnosis.The results suggest that, in order to prevent PODE, a great variance of MAP, higher doses of sevoflurane, and deep levels of anaesthesia should be avoided. Titrating sevoflurane according to end-tidal gas monitoring and vital signs can lead to unnecessarily deep or light hypnosis. Intraoperative EEG monitoring may help to prevent PODE.
33429798	41	63	postoperative delirium	Disease	MESH:D000071257
33429798	123	145	Postoperative delirium	Disease	MESH:D000071257
33429798	147	151	PODE	Disease	MESH:D000071257
33429798	404	415	sevoflurane	Chemical	MESH:D000077149
33429798	455	459	PODE	Disease	MESH:D000071257
33429798	474	485	sevoflurane	Chemical	MESH:D000077149
33429798	565	573	patients	Species	9606
33429798	605	613	patients	Species	9606
33429798	678	689	sevoflurane	Chemical	MESH:D000077149
33429798	694	704	sufentanil	Chemical	MESH:D017409
33429798	825	836	sevoflurane	Chemical	MESH:D000077149
33429798	863	867	PODE	Disease	MESH:D000071257
33429798	891	899	patients	Species	9606
33429798	913	918	women	Species	9606
33429798	932	935	men	Species	9606
33429798	947	951	PODE	Disease	MESH:D000071257
33429798	953	961	Patients	Species	9606
33429798	967	971	PODE	Disease	MESH:D000071257
33429798	1225	1236	sevoflurane	Chemical	MESH:D000077149
33429798	1301	1309	patients	Species	9606
33429798	1318	1322	PODE	Disease	MESH:D000071257
33429798	1476	1480	PODE	Disease	MESH:D000071257
33429798	1523	1534	sevoflurane	Chemical	MESH:D000077149
33429798	1596	1607	sevoflurane	Chemical	MESH:D000077149
33429798	1762	1766	PODE	Disease	MESH:D000071257
33429798	Association	MESH:D000077149	MESH:D000071257
33429798	Comparison	MESH:D000077149	MESH:D017409

